In the last trading session, 1.39 million Structure Therapeutics Inc ADR (NASDAQ:GPCR) shares changed hands as the company’s beta touched -1.72. With the company’s per share price at $25.91 changed hands at $2.29 or 9.70% during last session, the market valuation stood at $1.48B. GPCR’s last price was a discount, traded about -142.15% off its 52-week high of $62.74. The share price had its 52-week low at $13.22, which suggests the last value was 48.98% up since then. When we look at Structure Therapeutics Inc ADR’s average trading volume, we note the 10-day average is 1.5 million shares, with the 3-month average coming to 964.86K.
Analysts gave the Structure Therapeutics Inc ADR (GPCR) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended GPCR as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Structure Therapeutics Inc ADR’s EPS for the current quarter is expected to be -0.23.
Structure Therapeutics Inc ADR (NASDAQ:GPCR) trade information
Instantly GPCR was in green as seen at the end of in last trading. With action 12.46%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -4.46%, with the 5-day performance at 12.46% in the green. However, in the 30-day time frame, Structure Therapeutics Inc ADR (NASDAQ:GPCR) is 31.06% up. Looking at the short shares, we see there were 7.02 million shares sold at short interest cover period of 7.91 days.
The consensus price target for the stock as assigned by Wall Street analysts is 93, meaning bulls need an upside of 72.14% from its current market value. According to analyst projections, GPCR’s forecast low is 65 with 118 as the target high. To hit the forecast high, the stock’s price needs a -355.42% plunge from its current level, while the stock would need to soar -150.87% for it to hit the projected low.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -51.75%. The 2025 estimates are for Structure Therapeutics Inc ADR earnings to increase by 2.34%, but the outlook for the next 5-year period is at -25.24% per year.
GPCR Dividends
Structure Therapeutics Inc ADR is expected to release its next quarterly earnings report on 2025-Feb-26.
Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 5.99% of Structure Therapeutics Inc ADR shares while 110.15% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 117.18%. There are 110.15% institutions holding the Structure Therapeutics Inc ADR stock share, with WELLINGTON MANAGEMENT GROUP LLP the top institutional holder. As of 2024-06-30, the company held 1.7124% of the shares, roughly 7.55 million GPCR shares worth $296.41 million.
FMR LLC holds the second largest percentage of outstanding shares, with 1.3033% or 5.74 million shares worth $225.6 million as of 2024-06-30.
Among Mutual Funds, the top two as of Jan 31, 2025 were VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and SMALLCAP WORLD FUND INC . With 4.25 shares estimated at $110.1 million under it, the former controlled 7.41% of total outstanding shares. On the other hand, SMALLCAP WORLD FUND INC held about 6.38% of the shares, roughly 3.66 shares worth around $94.73 million.
